Login

I cannot remember my username

Our New Website Is Here!
As part of our merger with St. Paul Research, we’ve created a new website that will house all of our collective content under one roof, bringing you a higher level of research and service through our analysts’ combined insight, expertise, and perspective. Go to my.stpaulresearch.com to access our new site.

Breakthrough Technology Alert

This is the best time to be investing in world-changing technologies, as unprecedented innovations are taking off right now...

In Breakthrough Technology Alert, Ray Blanco tirelessly researches these exciting new breakthrough technologies and tells you exactly what you need to do to profit from them.

We Review Our Booming Portfolio

Ray Blanco
By Ray BlancoPosted February 16, 2021

2021 has opened strong for stocks, with the S&P 500 pulling a 5% gain just a month and a half into the year and the tech-heavy Nasdaq nearly doubling that. Overall, open positions in Breakthrough Technology Alert have been even stronger, with a lot of bright spots!

You Must Be A Subscriber To View This Content.

If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!

Breakthrough Technology Alert

This is the best time to be investing in world-changing technologies, as unprecedented innovations are taking off right now… Breakthrough Technology Alert tirelessly researches these exciting new breakthrough technologies to keep you well informed, outline specific opportunities, and keep you ahead of the game.

LoginGet Access

Ray Blanco

Ray Blanco

Ray Blanco is the editor of Technology Profits Confidential as well as Breakthrough Technology Alert, FDA Profit Alert, and Technology Profits Daily. Ray has been with Seven Figure Publishing since 2010. In 2019, his closed positions in Technology Profits Confidential outperformed the S&P500 by 50%.

View More By Ray Blanco

Related Posts

Two Biotech Innovators Cut Through Regulatory Rigmarole With Special Designations

Ray Blanco
By Ray BlancoPosted August 13, 2013

The Food and Drug Administration rules the pharmaceutical industry like Zeus from Mount Olympus. Its decrees have the power of virtual life or death for all promising biotechnology entrepreneurs hoping to operate in the world’s largest health care market. At any time, it can cast a lightning bolt on the best laid schemes of mice...

TOPICS | , , , ,

Thoughts on Star Scientific’s Tipping Point and 2012

Patrick Cox
By Patrick CoxPosted January 3, 2012

At a seasonal party a few nights ago, I was talking to eight or nine friends about the biggest events of 2011. Despite the fact that we are currently suffering a financial crisis of the same magnitude as the Great Depression or World War II, half of the people around the table agreed that the discovery of anatabine citrate, Anatabloc, ranked among the most-important developments of the year. Anatabloc, as you know, is produced by Star Scientific.

TOPICS | , , , ,

Thorium Power’s Agreement With Areva Could Power Your Portfolio Into the History Books

Patrick Cox
By Patrick CoxPosted July 28, 2009

Dear Breakthrough Technology Alert Reader, I’d like to follow up on the brief mention I made last week about Thorium Power Ltd. (THPW: OTCBB). I mentioned its filing of a Form 8-K, which is the SEC mandated means of announcing an unscheduled event or corporate change. This filing is, I believe, the most significant event...

TOPICS | , , , , ,

BioTime Announces Ultimate Stem Cell Gene Discovery

Patrick Cox
By Patrick CoxPosted January 24, 2012

Dear Breakthrough Technology Alert Reader, I had intended this week to review in some depth important events at Hadasit Bio-Holdings (TASE: HDST) and Provectus Pharmaceuticals (OTCBB: PVCT). Both have had important positive developments. Provectus has reported very positive interactions with the FDA, which waived an additional end-of-Phase II meeting as the company designs a planned...

TOPICS | , , , , ,